These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2943929)

  • 1. [Differentiation between mycobacterial species by the susceptibility test to ciprofloxacin--comparison of antimycobacterial spectra between ofloxacin and ciprofloxacin].
    Tsukamura M; Mizuno S
    Kekkaku; 1986 Jun; 61(6):357-9. PubMed ID: 2943929
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of in vitro growth-inhibitory activities of ofloxacin, ciprofloxacin and norfloxacin against various species of mycobacteria (comparison of organ concentrations and blood concentrations in mice)].
    Tsukamura M; Mizuno S; Toyama H
    Kekkaku; 1986 Sep; 61(9):453-9. PubMed ID: 3467134
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
    Thomas L; Naumann P; Crea A
    Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
    Saito H; Sato K; Tomioka H; Watanabe T
    Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
    Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ; Mallet MN; Gulian C; Terriou P; Lagier P; de Micco P
    Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimycobacterial activities of minocycline and ciprofloxacin].
    Arai T; Komatsu S; Aoyagi T
    Kekkaku; 1985 May; 60(5):293-7. PubMed ID: 3162057
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid.
    Casal M; Gutierrez J; González J; Ruiz P
    Chemioterapia; 1987 Dec; 6(6):437-9. PubMed ID: 3124964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.
    Young LS; Berlin OG; Inderlied CB
    Am J Med; 1987 Apr; 82(4A):23-6. PubMed ID: 3107379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimycobacterial activity of a new antibacterial substance DL-8280--differentiation between some species of mycobacteria and related organisms by the DL-8280 susceptibility test.
    Tsukamura M
    Microbiol Immunol; 1983; 27(12):1129-32. PubMed ID: 6587177
    [No Abstract]   [Full Text] [Related]  

  • 12. Differentiation of Mycobacterium nonchromogenicum from Mycobacterium terrae and Mycobacterium triviale by tests for susceptibility to ofloxacin (DL 8280) and by the developing pattern of petroleum-ether soluble sulfolipids on TLC.
    Tsukamura M; Mizuno S; Toyama H
    Microbiol Immunol; 1985; 29(4):365-70. PubMed ID: 2410764
    [No Abstract]   [Full Text] [Related]  

  • 13. Cryptolepine hydrochloride: a potent antimycobacterial alkaloid derived from Cryptolepis sanguinolenta.
    Gibbons S; Fallah F; Wright CW
    Phytother Res; 2003 Apr; 17(4):434-6. PubMed ID: 12722159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P; Mazzei T; Nicoletti P
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expectation of new antituberculous drugs and targeting therapy for treatment of mycobacterial infections].
    Tomioka H
    Kekkaku; 1993 Nov; 68(11):723-30. PubMed ID: 8264129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antituberculosis activity of a new antibacterial substance ofloxacin (DL8280).
    Tsukamura M
    Am Rev Respir Dis; 1985 Mar; 131(3):348-51. PubMed ID: 3919625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].
    Dabernat H; Delmas C; Lareng MB
    Pathol Biol (Paris); 1985 May; 33(5):385-8. PubMed ID: 3162140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
    Joly-Guillou ML; Bergogne-Berezin E
    Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
    Grimm H
    Arzneimittelforschung; 1985; 35(3):570-2. PubMed ID: 2986655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
    Grimaldo ER; Tupasi TE; Rivera AB; Quelapio MI; Cardaño RC; Derilo JO; Belen VA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.